Therapeutic Solutions International Inc (TSOI):製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】Therapeutic Solutions International Inc (TSOI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C8212)・商品コード:DATA904C8212
・発行会社(調査会社):GlobalData
・発行日:2018年10月
・ページ数:32
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Therapeutic Solutions International Inc (Therapeutic Solutions) is a pharmaceutical company that offers supplements. The company offers products such as DermalStilbene, NanoStilbene and ProJuvenol. Its ProJuvenol consists of anti-aging ingredients which helps for a healthy functionality for everyday living and promotes cellular rejuvenation. The company offers products in forms of syrups and capsules. Therapeutic Solutions also offers anti-ageing vitalization dietary supplement which increases the bone density, optimize hormone levels for body shaping, reduce fat, improve muscle tone, increase libido and sexual function, and decrease symptoms of stress and anxiety. It markets its products in the US and abroad. Therapeutic Solutions is headquartered in Oceanside, California?, the US.

Therapeutic Solutions International Inc (TSOI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Therapeutic Solutions International Inc, Medical Devices Deals, 2012 to YTD 2018 9
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Therapeutic Solutions Raises Funds through Venture Financing 11
Therapeutic Solutions International Raises USD0.1 Million in Venture Financing 12
Partnerships 13
Therapeutic Solutions Enters Into Distribution Agreement With S4S 13
Licensing Agreements 14
Emvolio Signs Patent Licensing Agreement with Therapeutics Solutions International 14
Emvolio Enters into Licensing Agreement with Therapeutic Solutions International 15
Emvolio Enters into Licensing Agreement with Therapeutics Solutions International for innaMune 16
Emvolio Enters into Licensing Agreement with Therapeutics Solutions International 17
Emvolio Enters into Patent Licensing Agreement with Therapeutics Solutions International 18
MolecuVax Enters into Licensing Agreement with UniVax 19
MolecuVax Enters into Licensing Agreement with Therapeutic Solutions International 20
Therapeutic Solutions International Enters into Licensing Agreement with Gustave Roussy 21
OmniBiome Therapeutics Enters into Licensing Agreement with Therapeutic Solutions International for the Treatment or Prevention of Pregnancy Complications 22
Therapeutic Solutions International Inc – Key Competitors 23
Therapeutic Solutions International Inc – Key Employees 24
Therapeutic Solutions International Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Corporate Communications 26
Jun 18, 2018: Therapeutic Solutions International Announces the Appointment of James Veltmeyer, MD as Chief Medical Officer 26
May 09, 2018: Therapeutic Solutions International Announces the Appointment of Nassir Azimi, MD, to Science Board 27
Feb 27, 2018: Therapeutic Solutions International Recruits Top Doctor of San Diego to Scientific Advisory Board 28
Oct 17, 2017: Therapeutic Solutions International strengthens the TSOI Scientific Advisory Board with the Appointment of Pablo A. Guzman, MD 29
May 01, 2017: Therapeutic Solutions International Announces Appointment of Dr. Thomas E. Ichim to its Subsidiary Emvolio 30
Product News 31
Jun 25, 2018: Therapeutic Solutions International releases “IsoStilbene” Injectable formulation of Pterostilbene under granted patent for augmentation of immunotherapy and targeting of cancer stem cells 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Therapeutic Solutions International Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Therapeutic Solutions International Inc, Medical Devices Deals, 2012 to YTD 2018 9
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Therapeutic Solutions Raises Funds through Venture Financing 11
Therapeutic Solutions International Raises USD0.1 Million in Venture Financing 12
Therapeutic Solutions Enters Into Distribution Agreement With S4S 13
Emvolio Signs Patent Licensing Agreement with Therapeutics Solutions International 14
Emvolio Enters into Licensing Agreement with Therapeutic Solutions International 15
Emvolio Enters into Licensing Agreement with Therapeutics Solutions International for innaMune 16
Emvolio Enters into Licensing Agreement with Therapeutics Solutions International 17
Emvolio Enters into Patent Licensing Agreement with Therapeutics Solutions International 18
MolecuVax Enters into Licensing Agreement with UniVax 19
MolecuVax Enters into Licensing Agreement with Therapeutic Solutions International 20
Therapeutic Solutions International Enters into Licensing Agreement with Gustave Roussy 21
OmniBiome Therapeutics Enters into Licensing Agreement with Therapeutic Solutions International for the Treatment or Prevention of Pregnancy Complications 22
Therapeutic Solutions International Inc, Key Competitors 23
Therapeutic Solutions International Inc, Key Employees 24
Therapeutic Solutions International Inc, Subsidiaries 25

List of Figures
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Therapeutic Solutions International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Therapeutic Solutions International Inc, Medical Devices Deals, 2012 to YTD 2018 9

★調査レポート[Therapeutic Solutions International Inc (TSOI):製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C8212)販売に関する免責事項を必ずご確認ください。
★調査レポート[Therapeutic Solutions International Inc (TSOI):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆